Development Level

Tbio 41 | 11,178
Tdark 20 | 6,569

IMPC Phenotype

abnormal behavior 2 | 298
decreased body weight 2 | 161
decreased hemoglobin content 2 | 68
trunk curl 2 | 16
abnormal bone mineralization 1 | 38
abnormal bone structure 1 | 187
abnormal kidney morphology 1 | 65
abnormal spinal cord morpholog... 1 | 9
abnormal vocalization 1 | 21
decreased bone mineral content 1 | 151
decreased bone mineral density 1 | 126
decreased caudal vertebrae num... 1 | 53
decreased circulating LDL chol... 1 | 38
decreased circulating free fat... 1 | 31
decreased circulating glucose ... 1 | 126
decreased lean body mass 1 | 135
decreased lumbar vertebrae num... 1 | 2
decreased mean corpuscular hem... 1 | 50
decreased mean corpuscular hem... 1 | 31
decreased sacral vertebrae num... 1 | 1
decreased total body fat amoun... 1 | 207
decreased vertical activity 1 | 208
increased circulating alkaline... 1 | 122
increased circulating calcium ... 1 | 34
increased circulating creatini... 1 | 38
increased circulating sodium l... 1 | 71
increased circulating triglyce... 1 | 42
increased fasted circulating g... 1 | 76
increased lean body mass 1 | 172
increased lumbar vertebrae num... 1 | 1
increased sacral vertebrae num... 1 | 1
increased startle reflex 1 | 112
increased total body fat amoun... 1 | 134
polycystic kidney 1 | 15
preweaning lethality, incomple... 1 | 499
shortened RR interval 1 | 17
thrombocytopenia 1 | 56
tremors 1 | 39

Disease

Carcinoma 25 | 11,192
lung adenocarcinoma 23 | 2,627
Breast cancer 22 | 3,469
psoriasis 21 | 6,514
lung cancer 19 | 4,607
ovarian cancer 17 | 8,297
invasive ductal carcinoma 15 | 2,867
breast carcinoma 14 | 1,589
osteosarcoma 14 | 7,766
atypical teratoid / rhabdoid tumor 12 | 4,971
malignant mesothelioma 12 | 3,135
non-small cell lung cancer 12 | 2,799
ductal carcinoma in situ 11 | 1,686
glioblastoma 11 | 5,635
medulloblastoma, large-cell 10 | 6,086
non-small cell lung carcinoma 10 | 302
pancreatic cancer 10 | 2,322
Cancer 9 | 2,388
intraductal papillary-mucinous carcinoma (IPMC) 9 | 2,902
colon cancer 8 | 1,428
cystic fibrosis 8 | 1,629
group 3 medulloblastoma 8 | 4,002
hepatocellular carcinoma 8 | 536
intraductal papillary-mucinous neoplasm (IPMN) 8 | 3,204
Multiple myeloma 7 | 1,296
cutaneous lupus erythematosus 7 | 1,016
gastric cancer 7 | 445
diabetes mellitus 6 | 1,683
lung carcinoma 6 | 2,755
pancreatic carcinoma 6 | 555
Endometriosis 5 | 521
Schizophrenia 5 | 1,136
acute myeloid leukemia 5 | 760
inflammatory breast cancer 5 | 272
pituitary cancer 5 | 1,915
primitive neuroectodermal tumor 5 | 2,957
Breast Neoplasms 4 | 423
Mammary Neoplasms 4 | 403
ependymoma 4 | 4,559
group 4 medulloblastoma 4 | 1,806
intraductal papillary-mucinous adenoma (IPMA) 4 | 2,872
spina bifida 4 | 1,053
subependymal giant cell astrocytoma 4 | 2,230
tuberculosis 4 | 1,963
Atopic dermatitis 3 | 915
Cleft Palate 3 | 265
Connective tissue disease 3 | 59
Intellectual disability 3 | 998
Lupus erythematosus 3 | 56
Male infertility 3 | 199
Multiple Sclerosis 3 | 527
nasopharyngeal carcinoma 3 | 1,024
pancreatic ductal adenocarcinoma liver metastasis 3 | 1,911
pediatric high grade glioma 3 | 1,035
sonic hedgehog group medulloblastoma 3 | 459
ulcerative colitis 3 | 1,765
Adenocarcinoma of lung 2 | 140
Adenoid Cystic Carcinoma 2 | 90
Ankylosing spondylitis 2 | 134
Astrocytoma, Pilocytic 2 | 3,006
Atypical teratoid rhabdoid tumor 2 | 6
Carcinoma, Adenoid Cystic 2 | 90
Disease Models, Animal 2 | 148
Down syndrome 2 | 480
Immune system cancer 2 | 136
Influenza 2 | 136
Lymphoid leukemia 2 | 156
Measles 2 | 22
Paratyphoid fever 2 | 10
Pick disease 2 | 1,856
Primary ciliary dyskinesia 2 | 75
Retinitis pigmentosa 11 2 | 58
Retinitis pigmentosa 20 2 | 5
Rheumatoid arthritis 2 | 1,156
Thyroiditis 2 | 28
active ulcerative colitis 2 | 736
acute quadriplegic myopathy 2 | 1,133
adrenocortical carcinoma 2 | 1,385
adult high grade glioma 2 | 3,701
astrocytic glioma 2 | 2,530
astrocytoma 2 | 1,113
interstitial cystitis 2 | 2,237
juvenile dermatomyositis 2 | 1,147
non primary Sjogren syndrome sicca 2 | 861
posterior fossa group A ependymoma 2 | 456
tuberculosis and treatment for 6 months 2 | 399
DOID:2627 1 | 89
Essential Hypertension 1 | 92
Fanconi anemia 1 | 56
Ganglioglioma 1 | 13
Gastric antral vascular ectasia 1 | 10
Malaria 1 | 155
Parkinson Disease 1 | 64
Pilocytic astrocytoma 1 | 54
Waldenstrons macroglobulinemia 1 | 742
X-linked cerebral adrenoleukodystrophy 1 | 114
active Crohn's disease 1 | 882
autosomal dominant Emery-Dreifuss muscular dystrophy 1 | 492
hereditary spastic paraplegia 1 | 313
progressive supranuclear palsy 1 | 656

Tissue

Endocrine System 58 | 18,159
Female tissues 56 | 17,400
Digestive Tract 54 | 17,369
Male tissues 54 | 17,142
Skin and soft tissues 54 | 17,230
Blood and immune system 53 | 16,909
Nervous System 53 | 16,725
Liver and Pancreas 52 | 16,750
Respiratory system 51 | 16,393
Urinary Tract 51 | 16,678
Cardiovascular System 50 | 15,192

Target Family

Non-IDG 57 | 12,091
Transcription Factor 4 | 1,400

PANTHER Protein Class (2)

histone 61 | 61
protein kinase 252 | 252
ribosomal protein 149 | 149
mRNA processing factor 118 | 118
calmodulin 113 | 113
chromatin/chromatin-binding pr... 106 | 106
serine protease 98 | 98
serine protease inhibitor 94 | 94
non-motor actin binding protei... 90 | 90
homeodomain transcription fact... 85 | 85
small GTPase 81 | 81
guanyl-nucleotide exchange fac... 77 | 77
translation factor 76 | 76
ligand-gated ion channel 69 | 69
microtubule binding motor prot... 62 | 62
cysteine protease 58 | 58
non-motor microtubule binding ... 57 | 57
kinase activator 55 | 55
chemokine 48 | 48
DNA-directed RNA polymerase 46 | 46
ribonucleoprotein 44 | 44
heterotrimeric G-protein 43 | 43
metalloprotease 43 | 43
protein phosphatase 41 | 41
nucleotide kinase 37 | 37
RNA helicase 35 | 35
phosphatase inhibitor 34 | 34
nucleotide phosphatase 33 | 33
actin and actin related protei... 31 | 31
kinase inhibitor 31 | 31
phospholipase 30 | 30
ATP synthase 28 | 28
DNA helicase 28 | 28
actin binding motor protein 27 | 27
calcium channel 23 | 23
DNA-directed DNA polymerase 22 | 22
endoribonuclease 22 | 22
tubulin 22 | 22
exoribonuclease 21 | 21
type I cytokine receptor 20 | 20
anion channel 19 | 19
carbohydrate kinase 17 | 17
endodeoxyribonuclease 15 | 15
intermediate filament binding ... 15 | 15
neuropeptide 15 | 15
potassium channel 15 | 15
DNA methyltransferase 12 | 12
aspartic protease 12 | 12
type II cytokine receptor 12 | 12
RNA methyltransferase 11 | 11
damaged DNA-binding protein 11 | 11
tumor necrosis factor family m... 11 | 11
sodium channel 9 | 9
neurotrophic factor 8 | 8
replication origin binding pro... 8 | 8
carbohydrate phosphatase 6 | 6
amino acid kinase 5 | 5
guanylate cyclase 5 | 5
interleukin superfamily 4 | 4
C2H2 zinc finger transcription... 3 | 3
CREB-related transcription fac... 3 | 3
DNA photolyase 2 | 2
DNA topoisomerase 2 | 2
Lambda repressor-like transcri... 2 | 2
cysteine protease inhibitor 2 | 2
tumor necrosis factor receptor 2 | 2
DNA glycosylase 1 | 1
DNA polymerase processivity fa... 1 | 1
centromere DNA-binding protein 1 | 1
exodeoxyribonuclease 1 | 1
phosphatase activator 1 | 1
primase 1 | 1
reverse transcriptase 1 | 1

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Histone H2A type 2-A HIST2H2AA3 Tbio Non-IDG -3.04065 999.3 88
Histone H2A type 2-C HIST2H2AC Tbio Non-IDG -3.03938 994.7 101
Histone H2B type 2-E HIST2H2BE Tbio Non-IDG -3.48425 2920.0 135
Histone H2A-Bbd type 2/3 H2AFB3 Tdark Non-IDG -0.25594 2.36 13
Mesoderm induction early response protein 1 MIER1 Tbio Non-IDG -2.21641 165.6 93
Histone H3.1t HIST3H3 Tbio Non-IDG -1.05426 10.9 1265
Histone H2B type 3-B HIST3H2BB Tbio Non-IDG -0.72238 5.02 53
Histone H2A type 1-D HIST1H2AD Tdark Non-IDG 0.17 0.32 11
Histone H2B type 2-F HIST2H2BF Tdark Non-IDG 0.52 0.19 121
Histone H2B type 1-K HIST1H2BK Tbio Non-IDG -0.50219 4.04 29